openPR Logo
Press release

Deadline on June 18, 2021 coming up in Lawsuit for Investors in Emergent BioSolutions Inc (NYSE: EBS)

06-11-2021 01:41 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

A Deadline is coming up on June 18, 2021 in the lawsuit for certain investors in Emergent BioSolutions Inc (NYSE: EBS).

A Deadline is coming up on June 18, 2021 in the lawsuit for certain investors in Emergent BioSolutions Inc (NYSE: EBS).

A deadline is coming up on June 18, 2021in the lawsuit filed for certain investors of Emergent BioSolutions Inc (NYSE: EBS) over alleged securities laws violations by Emergent BioSolutions Inc.

Investors who purchased shares of Emergent BioSolutions Inc (NYSE: EBS) have certain options and there are strict and short deadlines running. Deadline: June 18, 2021. NYSE: EBS stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

According to the complaint filed in the U.S. District Court for the District of Maryland the plaintiff alleges on behalf of purchasers of Emergent BioSolutions Inc (NYSE: EBS) common shares between July 6, 2020 and March 31, 2021, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between July 6, 2020 and March 31, 2021, the ompany failed to disclose to investors myriad issues at Bayview that would detrimentally affect its ability to manufacture the vaccine. Investors began to learn the truth on March 31, 2021, after the close of markets, when media reports revealed that employees at Emergent’s Bayview facility “mixed up” ingredients for the J&J and AstraZeneca vaccines, contaminating up to 15 million doses of the J&J vaccine. It was further revealed that this was not an isolated incident and part of a history of manufacturing issues at the Company’s plant. Media outlets called the massive contamination a “significant setback and public relations debacle” and highlighted longstanding contamination risks and quality control issues at the Company’s facilities, leading to a string of FDA citations, including a persistent problem with mold, poor disinfection of some plant equipment leading to growth of bacteria, the repeated approval of raw materials that had not been fully tested, and poor employee training.

Shares of Emergent BioSolutions Inc (NYSE: EBS) declined on April 22, 2021, to as low as $61.00 per share.

Those who purchased shares of Emergent BioSolutions Inc (NYSE: EBS) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Deadline on June 18, 2021 coming up in Lawsuit for Investors in Emergent BioSolutions Inc (NYSE: EBS) here

News-ID: 2302938 • Views: 215

More Releases from Shareholders Foundation

Lawsuit filed for Investors in shares of AcelRx Pharmaceuticals, Inc. (NASDAQ: A …
An investor, who purchased shares of AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX), filed a lawsuit over alleged violations of Federal Securities Laws by AcelRx Pharmaceuticals, Inc. Investors who purchased shares of AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) have certain options and for certain investors are short and strict deadlines running. Deadline: August 9, 2021. NASDAQ: ACRX investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. Redwood City, CA based
Deadline in Lawsuit for Investors in shares of Peloton Interactive, Inc. (NASDAQ …
A deadline is coming up on June 28, 2021 in the lawsuit filed for certain investors of Peloton Interactive, Inc. (NASDAQ: PTON) over alleged securities laws violations by Peloton Interactive, Inc. Investors who purchased shares of Peloton Interactive, Inc. (NASDAQ: PTON) have certain options and there are strict and short deadlines running. Deadline: June 28, 2021NASDAQ: PTON stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. According
Investors in shares of Oscar Health, Inc. (NYSE: OSCR) are encouraged to contact …
An investigation on behalf of investors of Oscar Health, Inc. (NYSE: OSCR) shares over potential securities laws violations by Oscar Health, Inc. and certain of its directors and officers in connection with certain financial statements was announced. Investors who purchased shares of Oscar Health, Inc. (NYSE: OSCR), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on
Investigation announced for Investors in. NYSE: RKT shares over possible Wrongdo …
An investigation on behalf of investors in shares of Rocket Companies, Inc. (NYSE: RKT) was announced over potential breaches of fiduciary duties by certain officers and directors at Rocket Companies, Inc. Investors who purchased shares of Rocket Companies, Inc. (NYSE: RKT) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Rocket Companies, Inc. directors breached

All 5 Releases


More Releases for Emergent

Process Burners Market Emergent Technology Advancement in Coming Year 2019-2023
The recent research report on the global Process Burners Industry market presents the latest industry data and future trends, allowing you to recognize the products and end users driving Revenue growth and profitability of the market. The report offers an extensive analysis of key drivers, leading market players, key segments, and regions. Besides this, the experts have deeply studied different geographical areas and presented a competitive scenario to assist new entrants,
Strain Gauges Market 2020 Emergent Technology Advancement in upcoming Years
Allied Market Research published a new report, titled, " Strain Gauges Market 2020 Emergent Technology Advancement in upComing Years." The report offers an extensive analysis of key growth strategies, drivers, opportunities, key segment, Porter's Five Forces analysis, and competitive landscape. This study is a helpful source of information for market players, investors, VPs, stakeholders, and new entrants to gain thorough understanding of the industry and determine steps to be taken
Biodefense Market Share 2017-2022 Emergent Biosolutions, Hytest, GSK, Sanofi
Global Biodefense Market Research Report 2012-2022 A recent report discusses the market study on "Biodefense Market" over the global and major regions, from angles of manufacturers, product types and end industries. This “Biodefense Market” research study involved the extensive usage of both primary and secondary data sources, The report on the global Biodefense market uses the top-down and bottom-up approaches to define, analyze, and describe the market trends and market
Global Naloxone Market 2017 : Fierce Pharma, Norwich Bulletin, Emergent BioSolut …
Global Naloxone Market 2016-2017 A market study based on the " Naloxone Market " across the globe, recently added to the repository of Market Research, is titled ‘Global Naloxone Market 2017’. The research report analyses the historical as well as present performance of the worldwide Naloxone industry, and makes predictions on the future status of Naloxone market on the basis of this analysis. Get Free Sample Copy of Report Here : http://www.marketsnresearch.com/request-for-sample.html?repid=8541 Top
Global Rotavirus Vaccine Market 2017 - GlaxoSmithKline, CSL Limited, Astellas Ph …
Global Rotavirus Vaccine Market 2017, presents a professional and in-depth study on the current state of the Rotavirus Vaccine market globally, providing basic overview of Rotavirus Vaccine market including definitions, classifications, applications and industry chain structure, Rotavirus Vaccine Market report provides development policies and plans are discussed as well as manufacturing processes and cost structures. Rotavirus Vaccine market size, share and end users are analyzed as well as segment markets
Emergent FinTech: Defining the Potential and Opportunities
Summary Fintech has the potential to transform banking. Start-ups are introducing new services that are making existing tasks easier and cheaper to perform. They are also creating new markets, with the attendant prospect of new revenue streams. Although these developments could threaten the established banks, they also offer providers the chance to reinvent themselves and reconnect with their customers. Request Sample Report: http://www.reportbazzar.com/request-sample/?pid=439916&ptitle=Emergent+FinTech%3A+Defining+the+Potential+and+Opportunities&req=Sample Synopsis – Find out which areas of retail banking are most